Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ: INBS )

1.390 +0.080 (+6.11%)
Streaming Delayed Price Updated: 3:59 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Intelligent Bio Solutions Inc. - Common Stock

< Previous 1 2 3 Next >
Intelligent Bio (NASDAQ: INBS) Announces New Zealand Expansion: Medical Stocks Growing Momentum” INBS, XTRX, CNXA, DNA
Via AB Newswire
Topics Economy
Exposures Interest Rates
Intelligent Bio Solutions Inc. (NASDAQ: INBS): “Fingerprint Sweat Analysis: Revolutionizing Drug Screening with Speed and Precision” (JAGX, BCEL, CDIO)
Via AB Newswire
Topics Cannabis
Exposures Cannabis
Intelligent Bio Solutions Inc. (Nasdaq: INBS) Groundbreaking Health and Drug Screenings Revolutionize Healthcare and Work Environments: MXCT, CERS, NVOS
Via AB Newswire
Topics Cannabis
Exposures Cannabis
Intelligent Bio Solutions (NASDAQ: INBS) Launches Global Expansion of Its Cutting-Edge Intelligent Drug Screening System
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Biotech Stocks: Exciting Breakthroughs and Emerging Trends to Watch – INBS, HUMA, HRTX, HALB, RMED
Via AB Newswire
Unveiling SmallCap Biotech Stocks to Watch: INBS, CERS, HIMS
Via AB Newswire
TheStreetReports: AI Biomedical Companies Disrupting Healthcare: INBS, DNA, IBRX, CDIO
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
Intelligent Bio Solutions (NASDAQ:INBS): AI Biotech Company Utilizing Fingerprint Technology In Focus
Via AB Newswire
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death
Intelligent Bio Solutions (NASDAQ: INBS) Completes Notable Milestone in Development of its Biosensor Diagnostic Platform
Intelligent Bio Solutions, Inc. (NASDAQ: INBS) operates as a life sciences company, which is focused on the development of non-invasive, 
Via Spotlight Growth
Intelligent Bio Solutions Inc. Reports First Quarter Ending September 30, 2022, Preliminary Financial Results and Recent Business Highlights
From Intelligent Bio Solutions, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Inc. (INBS) Announces UK-Wide Glass Manufacturer to Roll Out Non-Invasive Drug Screening System Across UK Operations
- Can now test 1,000 employees across six sites as required, with each test always taking only ten minutes - 
From Intelligent Bio Solutions, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Inc. Announces Airline Adopts Fingerprint Drug Screening System for In-house Testing
From Intelligent Bio Solutions, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Inc. to Present First Quarter 2023 Financial Results and Recent Corporate Update on November 9
- Company to Host Conference Call & Webcast at 4:30 p.m. ET - 
From Intelligent Bio Solutions, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.